Abstract
Daniel Longnecker is a worldwide-recognized pancreatologist for his contribution to the understanding of the pathogenesis of pancreatic diseases. He was a pioneer in the development of animal models for pancreatic disorders, in particular pancreatic cancer. In addition, he led the way in the characterization and classification of the lesions involved in pancreatic neoplasias. In this interview, Professor Longnecker comments on his experience in pancreatic research and provides advice to new investigators in this field.
This content is only available via PDF.
© 2006 S. Karger AG, Basel and IAP
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.